Clinuvel Pharmaceuticals (CUV.AU) Q1 2024 Earnings

Feb 22Confirmed
Q3 2022
Q1 2023
Q3 2023
Q1 2024
0.21
0.26
0.32
0.37

Details

Expected EPS
N/A
Actual EPS
0.21
Surprise EPS
N/A
Surprise Percent
N/A

Description

⁨Clinuvel Pharmaceuticals⁩ (⁦CUV.AU⁩) has reported earnings of ⁦0.21⁩ per share for ⁦Q1 2024⁩.

0 Comments

Share your thoughts